Recurrent ulcer


Also found in: Encyclopedia.

marginal ulcer

A term of art for ulcers that develop at the margins of a gastrojejunostomy, primarily on the jejunal side. Most marginal ulcers respond to medical therapy, but complicated or complex lesions require further intervention.

Surgical management
• Omental (Graham) patch repair;
• Revision of gastrojejunostomy;
• Irrigation and drainage;
• Any prior procedure with truncal vagotomy;
• Oesophagojejunostomy; and
• Reversal.

Recurrent ulcer

Stomach ulcers that return after apparently complete healing. These ulcers appear to be caused by helicobacter pylori infections and can generally be successfully treated with a combination of antibiotics and gastric acid reducing compounds, particularly the proton pump inhibitors.
References in periodicals archive ?
He also talked about recurrent ulcers. Total destruction of a weight bearing joint is marked by bony destruction, Charcot osteoarthropathy is most overlooked serious limb-threatening complication of diabetes - Prof.Bilal Bin Younis bone resorption and eventual deformity.
pylori infection) remained predictors for recurrent ulcer in patients with previous gastric surgery for PUD in our work, except for alcohol consumption and biliary reflux.
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
Research has shown that a significant number of patients with atherosclerosis who have a history of peptic ulcer will develop recurrent ulcers during treatment with clopidogrel.
Combination of a cyclo-oxygenase-2 inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a randomised double-blind trial.
This recommendation has been controversial, but current evidence suggests this strategy reduces the risk of recurrent ulcer bleeding.
Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.
The 13-month cumulative incidence of recurrent ulcer bleeding in this trial was 0% in subjects randomized to the combination therapy, compared with 8.9% in controls on celecoxib (Celebrex) plus placebo, Dr.
Chan, M.D., of the Chinese University of Hong Kong and his associates reported that recurrent ulcer bleeding occurred at a significantly higher rate in 161 patients who received clopidogrel (Plavix) plus a placebo than in 159 patients who received aspirin plus esomeprazole (Nexium) during a median follow-up of 12 months (8.6% vs.
pylori eradication is associated with a low rate of recurrent ulcer hemorrhage and suggest that H.

Full browser ?